These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 9704432)
1. What future means to management of blood centres. van Aken WG Vox Sang; 1998; 74 Suppl 2():115-8. PubMed ID: 9704432 [No Abstract] [Full Text] [Related]
2. Current and emerging infectious risks of blood transfusions. Busch MP; Kleinman SH; Nemo GJ JAMA; 2003 Feb; 289(8):959-62. PubMed ID: 12597733 [No Abstract] [Full Text] [Related]
4. Blood & politics. Titus K CAP Today; 1996 Mar; 10(3):20, 22-4. PubMed ID: 10160264 [No Abstract] [Full Text] [Related]
5. UK patient first to contract vCJD via blood transfusion. Sibbald B CMAJ; 2004 Mar; 170(7):1087. PubMed ID: 15051685 [No Abstract] [Full Text] [Related]
6. The impact of improved safety on maintaining a sufficient blood supply. Reynolds E; Wickenden C; Oliver A Transfus Clin Biol; 2001 Jun; 8(3):235-9. PubMed ID: 11499967 [TBL] [Abstract][Full Text] [Related]
7. Donor selection: the exclusion of high risk donors? van den Burg PJ; Vrielink H; Reesink HW Vox Sang; 1998; 74 Suppl 2():499-502. PubMed ID: 9704489 [TBL] [Abstract][Full Text] [Related]
8. International views on universal leucodepletion: the perspective in Germany. Seitz MD Transfus Sci; 1998 Dec; 19(4):359-60. PubMed ID: 10351155 [No Abstract] [Full Text] [Related]
10. The sensibility of safety: reflections on the Krever inquiry's final report. Hoey J CMAJ; 1998 Jan; 158(1):59-60. PubMed ID: 9475910 [No Abstract] [Full Text] [Related]
11. Donor pool size and the risk of blood-borne Creutzfeldt-Jakob disease. Brown P Transfusion; 1998 Mar; 38(3):312-5. PubMed ID: 9563414 [No Abstract] [Full Text] [Related]
12. Implications of notifying donors and recipients. Hewitt PE Vox Sang; 2004 Jul; 87 Suppl 2():1-2. PubMed ID: 15209865 [No Abstract] [Full Text] [Related]
13. Ireland fears blood shortage with new ban on donors. Payne D BMJ; 2001 Sep; 323(7311):469. PubMed ID: 11532827 [No Abstract] [Full Text] [Related]
14. Creutzfeldt-Jakob disease and blood transfusion. Watkins AM BMJ; 1991 Jun; 302(6791):1537. PubMed ID: 1781826 [No Abstract] [Full Text] [Related]
16. The donor of blood and its components. Högman CF Schweiz Med Wochenschr Suppl; 1991; 43():111-4. PubMed ID: 1843033 [No Abstract] [Full Text] [Related]
17. Variant Creutzfeldt-Jakob disease in Australian blood donors: estimation of risk and the impact of deferral strategies. Correll PK; Law MG; Seed CR; Gust A; Buring M; Dax EM; Keller AJ; Kaldor JM Vox Sang; 2001 Jul; 81(1):6-11. PubMed ID: 11520409 [TBL] [Abstract][Full Text] [Related]
18. Blood transfusion medicine. Regan F; Taylor C BMJ; 2002 Jul; 325(7356):143-7. PubMed ID: 12130612 [No Abstract] [Full Text] [Related]
19. Future trends in blood component preparation. van Aken WG Vox Sang; 1986; 51 Suppl 1():67-71. PubMed ID: 3739333 [TBL] [Abstract][Full Text] [Related]
20. Public health. French Supreme Court ends tainted blood saga. Casassus B Science; 2003 Jun; 300(5628):2019. PubMed ID: 12829758 [No Abstract] [Full Text] [Related] [Next] [New Search]